Status:
COMPLETED
Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may al...
Detailed Description
OBJECTIVES: * Identify gene expression profiles associated with survival by DNA microarray assay analysis using RNA from formalin-fixed paraffin-embedded tissue samples from patients with squamous ce...
Eligibility Criteria
Inclusion
- Diagnosis of squamous cell carcinoma of the head and neck, including 1 of the following sites:
- Hypopharynx
- Larynx
- Oral cavity
- Oropharynx
- Stage II-IV disease
- Must have received treatment on clinical trial RTOG-9501
- Formalin-fixed paraffin-embedded tissue samples available
Exclusion
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00897052
Start Date
February 1 2005
End Date
December 1 2007
Last Update
September 10 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.